Fascinating look into medical/pharma issues
☆
☆
☆
☆
☆
“Dr Prasad is a voice of reason in these stupid times. I enjoy the Covid talk but also his breakdown of big pharma motives and MOs around drug creation and approval. I am a non medical professional but a lot of his statistical talk makes me consider how I approach my own industry and the claims vs reality we put out to the public. Great listen!”
RVWgrande via Apple Podcasts ·
United States of America ·
05/08/22
More reviews of Plenary Session
☆
☆
☆
☆
☆
“Extremely well articulated arguments for more rational clinical trial design. I love the interviews.”
David 3687 via Apple Podcasts ·
United States of America ·
12/16/18
☆
☆
☆
☆
☆
“Dr. Prasad’s podcast has been a treat for me since I was introduced to it by a mentor of mine. His presentations of information and opinions are artfully composed. His well-reasoned arguments on the worthiness of a trial to win FDA approval to resident development are predictably a pleasure to...”Read full review »
CBS86 via Apple Podcasts ·
United States of America ·
12/24/18
☆
☆
☆
☆
☆
“A brilliant podcast that dives deeply into many issues germane to the current oncology drug development world. Dr. Prasad is a great host who clearly thinks through the complex issues in clinical research and epidemiological studies. He is thoughtful and incredibly articulate without being...”Read full review »
Peaceomind77 via Apple Podcasts ·
United States of America ·
01/10/20
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
Listen now
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
